StreetInsider.com News Articles

Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

Wed, 22 Jul 2026 16:05:00 -0400

IRVING, Texas--(BUSINESS WIRE)-- biote Corp. (Nasdaq: BTMD) (“Biote” or the “Company”), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our Practitioners’ patients, today announced the Company will provide second quarter financial results on Wednesday, August 5, 2026, after the close of the market. A conference call to discuss the firm’s results will be held at 5:00 p.m. ET the same day.

Conference Call Details

The conference call may be accessed by dialing (646) 307-1963 (U.S. toll-free) or (800) 715-9871 (International) and referencing conference ID: 1792102. The live webcast of the call can

Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

Wed, 22 Jul 2026 16:05:00 -0400

Conference Call Details

The conference call may be accessed by dialing (646) 307-1963 (U.S. toll-free) or (800) 715-9871 (International) and referencing conference ID: 1792102. The live webcast of the call can

Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

Wed, 22 Jul 2026 16:05:00 -0400

Conference Call Details

The conference call may be accessed by dialing (646) 307-1963 (U.S. toll-free) or (800) 715-9871 (International) and referencing conference ID: 1792102. The live webcast of the call can

Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call

Wed, 22 Jul 2026 16:05:00 -0400

Conference Call Details

The conference call may be accessed by dialing (646) 307-1963 (U.S. toll-free) or (800) 715-9871 (International) and referencing conference ID: 1792102. The live webcast of the call can

Form 4 biote Corp. For: Jun 12 Filed by: Peterson Robert Charles

Tue, 16 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260616/26655244.html

Form 4 biote Corp. For: Jun 12 Filed by: Peterson Robert Charles

Tue, 16 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260616/26655244.html

Form 4 biote Corp. For: Jun 08 Filed by: Christensen Bret

Wed, 10 Jun 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260610/26630844.html

Form 4 biote Corp. For: Jun 08 Filed by: Christensen Bret

Wed, 10 Jun 2026 17:13:00 -0400

si-local-file:///var/storage/secattach/20260610/26630844.html

Form 4 biote Corp. For: Jun 08 Filed by: Beer Marc D

Wed, 10 Jun 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260610/26630832.html

Form 4 biote Corp. For: Jun 08 Filed by: Beer Marc D

Wed, 10 Jun 2026 17:11:00 -0400

si-local-file:///var/storage/secattach/20260610/26630832.html

Biote names Komal Bajaj as chief medical officer

Mon, 01 Jun 2026 08:02:37 -0400

Biote Corp. (NASDAQ: BTMD) appointed Komal Bajaj as chief medical officer, effective June 1, 2026, according to a company statement.

Dr. Bajaj is a board-certified OB/GYN and reproductive geneticist with more than 20 years of experience in clinical practice, healthcare quality, and systems leadership. She previously served as Chief Quality Officer for Jacobi Hospital and North Central Bronx Hospital within NYC Health + Hospitals, overseeing quality and safety programs for approximately one million patients.

The Irving, Texas-based hormone optimization company said Dr. Bajaj has led healthcare transformation initiatives involving artificial intelligence governance, simulation-based workforce training, and patient safety modernization. She contributed to

Biote names Komal Bajaj as chief medical officer

Mon, 01 Jun 2026 08:02:37 -0400

Biote Corp. (NASDAQ: BTMD) appointed Komal Bajaj as chief medical officer, effective June 1, 2026, according to a company statement.

Biote names Komal Bajaj as chief medical officer

Mon, 01 Jun 2026 08:02:37 -0400

Biote Corp. (NASDAQ: BTMD) appointed Komal Bajaj as chief medical officer, effective June 1, 2026, according to a company statement.

Biote names Komal Bajaj as chief medical officer

Mon, 01 Jun 2026 08:02:37 -0400

Biote Corp. (NASDAQ: BTMD) appointed Komal Bajaj as chief medical officer, effective June 1, 2026, according to a company statement.

Biote names Komal Bajaj as chief medical officer

Mon, 01 Jun 2026 08:02:37 -0400

Biote Corp. (NASDAQ: BTMD) appointed Komal Bajaj as chief medical officer, effective June 1, 2026, according to a company statement.

Biote names Komal Bajaj as chief medical officer

Mon, 01 Jun 2026 08:02:37 -0400

Biote Corp. (NASDAQ: BTMD) appointed Komal Bajaj as chief medical officer, effective June 1, 2026, according to a company statement.

Biote Appoints Komal Bajaj, MD, MS as Chief Medical Officer